Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.18 | N/A |
PEG Ratio (TTM) | -0.15 | N/A |
P/S Ratio (TTM) | 0.26 | N/A |
P/B Ratio (TTM) | 0.52 | N/A |
P/FCF Ratio (TTM) | 35.83 | N/A |
Price to 5YR AVG Earnings Ratio | -0.15 | N/A |
Price to 5YR AVG FCF Ratio | -0.26 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -34.13% | N/A |
ROE (TTM) | -40.87% | N/A |
Net Profit Margin (TTM) | -22.08% | N/A |
ROIC 5YR AVG | -131.02% | N/A |
Growth (23%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -169.91% | -4.75% | 2.93% |
Revenue | -3.34% | 55.36% | 42.93% |
Net Income | -138.60% | -11.98% | -2.94% |
Cash Flow | -28.49% | -32.18% | 5.52% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.59 | N/A |
Quick Ratio (TTM) | 3.58 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 1.27 | N/A |
LTL to 5YR AVG FCF | 0.00 | N/A |
Shares Outstanding Growth 5YR AVG | 6.87% | N/A |